表紙:幹細胞市場:タイプ別、用途別、技術別、地域別- 規模、シェア、展望、機会分析、2023年~2030年
市場調査レポート
商品コード
1350299

幹細胞市場:タイプ別、用途別、技術別、地域別- 規模、シェア、展望、機会分析、2023年~2030年

Stem Cells Market, by Type, by Application, by Technology and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 170 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
幹細胞市場:タイプ別、用途別、技術別、地域別- 規模、シェア、展望、機会分析、2023年~2030年
出版日: 2023年08月25日
発行: Coherent Market Insights
ページ情報: 英文 170 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の幹細胞市場は、2023年には129億米ドルに達すると推定・予測され、予測期間中(2023-2030年)のCAGRは9.1%になると予測されています。

レポート範囲 レポート詳細
基準年 2022 2023年の市場規模 129億米ドル
過去データ 2018年から2021年 予測期間 2023-2030
予測期間2023年~2030年 CAGR: 9.10% 2030年の価値予測 237億米ドル
Stem Cells Market-IMG1

市場力学

科学研究機関の研究者による研究開発活動の活発化が、世界の幹細胞市場の成長に寄与しています。例えば、2022年8月、イスラエルのレホボトにある公立研究大学ワイツマン科学研究所の科学者たちは、幹細胞のみから臓器の前駆細胞を備えた生きたまま成長するマウス胚を作り出すことに成功しました。

研究の主な特徴

  • 本レポートは、世界の幹細胞市場を詳細に分析し、2022年を基準年とした予測期間(2023-2030年)の市場規模および複合年間成長率(CAGR)を提供します。
  • また、異なるセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の幹細胞市場における主な企業を、企業プロファイル、製品ポートフォリオ、主なハイライト、業績、戦略などのパラメータに基づいて紹介しています。
  • 本調査の対象となる主要企業には、Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation(A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.が含まれます。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 世界の幹細胞市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の幹細胞市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概況

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 最近の製品上市
  • 疫学
  • 合併、買収、提携
  • 規制シナリオ
  • 主な発展
  • PEST分析

第4章 幹細胞の世界市場-COVID-19影響分析

  • 経済的影響
  • COVID-19疫学
  • 需給への影響

第5章 幹細胞の世界市場:タイプ別、2018-2030年

  • 成体幹細胞
  • ヒト胚性幹細胞
  • 人工多能性幹細胞
  • 天然ロゼット細胞
  • 極小胚様幹細胞

第6章 幹細胞の世界市場:用途別、2018-2030年

  • 再生医療
  • 創薬と医薬品開発

第7章 幹細胞の世界市場:技術別、2018-2030年

  • 細胞の取得
  • 細胞生産
  • 凍結保存
  • 増殖とサブカルチャー

第8章 幹細胞の世界市場:地域別、2018-2030年

  • 北米
  • 米国
  • カナダ
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • 中東
  • GCC
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第9章 競合情勢

  • Advanced Cell Technology, Inc
  • Angel Biotechnology Holdings PLC
  • Biotricity
  • Lineage Cell Therapeutics, Inc.
  • BrainStorm Cell Limited.
  • CIRM
  • Celgene Corporation(A subsidiary of Bristol-Myers Squibb Company)
  • Takara Bio Inc.
  • Cellular Engineering Technologies.
  • Cytori Therapeutics Inc.
  • STEMCELL Technologies

第10章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI4222

The global stem cells market is estimated to be valued at US$ 12.9 Bn in 2023 and is expected to exhibit a CAGR of 9.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 12.9 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.10% 2030 Value Projection: US$ 23.7 Bn
Stem Cells Market - IMG1

Stem cells are the body's raw materials-cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells become either new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new cell types. Stem cells may one day be used to make cells and tissues for the therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis. Stem cells are different from other cells in the body in three ways:

  • Stem cells can divide and renew itself over a long period of time
  • Stem cells are unspecialized, so it cannot do specific functions in the body
  • Stem cells have the potential to become specialized cells, such as muscle cells, blood cells, and brain cells

Market Dynamics

Increasing research and development activities conducted by researchers in science institutes are contributing to the growth of the global stem cells market. For instance, in August 2022, scientists from the Weizmann Institute of Science, a public research university in Rehovot, Israel, successfully generated living, growing mouse embryos complete with organ progenitors from stem cells alone-and they did it entirely ex utero, keeping them alive for eight days with the aid of an artificial womb that previously maintained harvested embryos until they were 11 days old.

Key features of the study:

  • This report provides an in-depth analysis of the global stem cells market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global stem cells market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cells market.

Detailed Segmentation:

  • Global Stem Cells Market, By Type:
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market, By Application:
    • Regenerative Medicine
    • Drug Discovery and Development
  • Global Stem Cells Market, By Technology:
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Advanced Cell Technology, Inc.
    • Angel Biotechnology Holdings PLC
    • Biotricity
    • Lineage Cell Therapeutics, Inc.
    • BrainStorm Cell Limited.
    • CIRM
    • Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
    • Takara Bio Inc.
    • Cellular Engineering Technologies.
    • Cytori Therapeutics Inc.
    • STEMCELL Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Technology
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Stem Cells Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Stem Cells Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Adult Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Human Embryonic Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Induced Pluripotent Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Natural Rosette Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Very Small Embryonic Like Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Stem Cells Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Stem Cells Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cell Acquisition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cell Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cryopreservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Expansion and Sub-Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Stem Cells Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018- 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Advanced Cell Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Angel Biotechnology Holdings PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotricity
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lineage Cell Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BrainStorm Cell Limited.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CIRM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cellular Engineering Technologies.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cytori Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us